Routine African introduction to begin in Sudan

UNITAID funding decision expected later this summer

New center will combine PATH’s expertise across early discovery, preclinical and clinical testing, regulatory affairs, manufacturing, and vaccine introduction and delivery

Officials at Addis conference plan transition from mass campaigns to use in childhood immunization programs to prevent resurgence of deadly epidemics

Submit an abstract, register for the conference, or apply for a travel grant on the conference website

Theme issue and policy discussion mark the midpoint of the Decade of Vaccines

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall

PATH experts make the case in special issue of the journal Vaccine

Decision paves the way for World Health Organization to assess how a malaria vaccine might be used in young children in sub-Saharan Africa

Injected, non-replicating vaccines hold potential for expanded impact in developing countries

Final results from Phase III trial suggest substantial public health benefits could be provided by the RTS,S malaria vaccine candidate in endemic regions in sub-Saharan Africa; vaccine efficacy enhanced by administration of a booster dose

National launch signifies PATH’s decade-long work to bring a lifesaving vaccine to at-risk countries

ROTAVAC® has the potential to significantly reduce the incidence of severe diarrhea due to rotavirus among children in India

MenAfriVac’s® introduction in routine childhood immunization programs will sustain long-term disease control in the region

Grant from Gates Foundation to PATH Malaria Vaccine Initiative

Vaccine/adjuvant combination against a leading cause of bacterial diarrhea shows great promise for saving children’s lives

New award from the Wellcome Trust will support the clinical development of a vaccine against Shigella for children in the developing world

Article in The Lancet provides safety and efficacy data from phase 3 trial of ROTAVAC®

A second study by World Health Organization suggests keeping vaccines at ambient temperatures during campaigns could cut storage and transportation costs in half

PATH receives two Grand Challenges Explorations grants to advance a new class of cold chain equipment and simplify human milk banking systems

Ashley Birkett, PhD, to lead key product development program at PATH

Milestone marks the first prequalified JE vaccine for children and the first Chinese vaccine manufacturer to achieve prequalification

Breakthrough health innovations could save 1.2 million mothers and children by the end of 2015

Study in The Lancet shows remarkable effectiveness of vaccine developed through a PATH-WHO partnership

International conference showcases recent innovations in skin-mediated vaccination advanced by PATH and partners

PATH will lead five-year, multi-million dollar initiative aimed at creating transformative impact to increase immunization coverage

Partners announce positive phase 3 clinical trial results for affordable rotavirus vaccine

Dose-reduction strategies could help conserve 420 million doses of yellow fever vaccine by 2022, new report concludes

Supplement from the journal Vaccine explores opportunities and challenges of the Global Vaccine Action Plan

Document provides ambitious framework for expanding vaccine access

New video highlights importance of strengthening vaccine supply and logistics systems

Trio recognized for advancing vaccines for low-resource settings

Advocacy efforts led by PATH help safeguard access to vaccines in treaty limiting mercury in the environment

Follow-on agreement will lead to clinical trials

Longtime PATH leader honored by Vietnam’s Ministry of Health

Affordable, safe, effective vaccine protecting young people from devastating disease

Innovation helps to ensure vaccine performance and effectiveness outside of the cold chain

New flexibility to help expand access to MenAfriVac®, as Benin prepares to roll out vaccine that scientists say is having dramatic impact on disease